Drug
QL2107
QL2107 is a pharmaceutical drug with 5 clinical trials. Currently 3 active trials ongoing.
Total Trials
5
Max Phase
—
Type
DRUG
Molecule
—
Success Metrics
Active Trials
3(60%)
Phase Distribution
Ph phase_1
3
60%
Ph phase_3
2
40%
Phase Distribution
3
Early Stage
0
Mid Stage
2
Late Stage
Phase Distribution5 total trials
Phase 1Safety & dosage
3(60.0%)
Phase 3Large-scale testing
2(40.0%)
Highest Phase Reached
Phase 3Trial Status & Enrollment
Completion Rate
0.0%
0 of 0 finished
Non-Completion Rate
0.0%
0 ended early
Currently Active
3
trials recruiting
Total Trials
5
all time
Status Distribution
Active(4)
Other(1)
Detailed Status
Recruiting3
Not yet recruiting1
unknown1
Development Timeline
Analytics
Development Status
Total Trials
5
Active
3
Success Rate
N/A
Most Advanced
Phase 3
Trials by Phase
Phase 13 (60.0%)
Phase 32 (40.0%)
Trials by Status
not_yet_recruiting120%
recruiting360%
unknown120%
Recent Activity
3 active trials
Showing 5 of 5
recruitingphase_1
A Study of QLP2117 in Combination With QL2107 in Advanced Solid Tumor Patients
NCT06911827
recruitingphase_1
A Study of QLC5508 Combinations in Patients With Advanced Solid Tumors
NCT07256782
not_yet_recruitingphase_3
Pharmacokinetic Study of QL2107 Versus Keytruda® for Adjuvant Therapy of Non-Small Cell Lung Cancer (NSCLC)
NCT07162883
recruitingphase_3
A Study to Evaluate Efficacy, and Safety of QL2107 Plus Chemo and Compare With Keytruda in Participants With IV nqNSCLC
NCT06754644
unknownphase_1
A Study Comparing Pharmacokinetic and Safety of QL2107 and Keytruda® (Marketed in China and the United States) in Healthy Adults
NCT06173011
Clinical Trials (5)
Showing 5 of 5 trials
NCT06911827Phase 1
A Study of QLP2117 in Combination With QL2107 in Advanced Solid Tumor Patients
NCT07256782Phase 1
A Study of QLC5508 Combinations in Patients With Advanced Solid Tumors
NCT07162883Phase 3
Pharmacokinetic Study of QL2107 Versus Keytruda® for Adjuvant Therapy of Non-Small Cell Lung Cancer (NSCLC)
NCT06754644Phase 3
A Study to Evaluate Efficacy, and Safety of QL2107 Plus Chemo and Compare With Keytruda in Participants With IV nqNSCLC
NCT06173011Phase 1
A Study Comparing Pharmacokinetic and Safety of QL2107 and Keytruda® (Marketed in China and the United States) in Healthy Adults
All 5 trials loaded
Drug Details
- Intervention Type
- DRUG
- Total Trials
- 5